Austin Engineering appoints new CEO
Mining equipment manufacturer Austin Engineering has appointed David Singleton (pictured) as CEO and managing director after a period acting in the position. Singleton is credited with internationalising Perth shipbuilder Austal and taking it into new areas of technology including naval shipbuilding and construction using steel instead of its more typical aluminium vessels. Singleton has had a stellar business career including as CEO of Poseidon Nickle, Alenia Marconi Systems and Clough, and global head of strategy for BAE Systems. Austin, which manufactures surface and underground dump truck bodies, buckets, water tanks and ancillary equipment, recently rationalised its South American operations and moved its headquarters from Brisbane to co-locate with its largest factory at Kewdale in Perth.
Spectur announces record revenues
Internet of things solar security solutions provider Spectur has announced new revenue records for its latest quarter, half and full year results. Sectur achieved fourth quarter revenue of $1.8 million, half year revenue of $3.2 million and full year revenue of $5.2 million. Fourth quarter sales of 134 units were up from 91 in the previous quarter. In February it announced its largest sales contract to date for an emergency response beacon network for Surf Lifesaving New South Wales.
Titomic completes acquisition, establishes Titomic USA
Additive manufacturing technology company Titomic has completed the acquisition of Tri-D Dynamics Inc, a Silicon Valley manufacturing technology company focusing on smart pipeline manufacture. Titomic USA completed the acquisition, which the company described as another milestone in its strategy to be a global solutions leader in additive manufacturing. Tri-D aims to upgrade and electrify infrastructure by embedding electronics directly into metal structures to outfit them with digital technology. Titomic is commercialising its Titomic Kinetic fusion technology (TKF) additive manufacturing process.
Medlab progresses non-opioid paid medication trials
Medlab Clicical has received ethics approval to proceed with human trials of its NanaBis cancer bone pain phase 3 trial. NanaBis is Medlab’s non-opioid pain medication which utilises the company’s NanoCelle drug delivery platform. ethics committee Belberry has approval trials by investigator Professor Stephen Clarke at GenesisCare in Sydney, and Professor Phil Good at the Mater Hospital Brisbane. Two other sites are also being considered for the trials.
Archer reports on-chip qubit control
Materials development company Archer Materials has reported progress in its development of a quantum computing CQ chip, with the first quantum information signals detected that indicate on-chip qubit control. Archer recorded ‘continuous wave electron resonance’ signals – in quantum computers information is stored according to the spin of electrons surrounding an atomic nucleus. The signals were picked up from a device integrating microscopic quantities of qubits, the quantum mechanical analogue of a classical bit.
Picture: Wintermute Biomedical
Subscribe to our free @AuManufacturing newsletter here.